SPRO vs TYL · P/E 9.6, rev $258.0K vs P/E 89, rev $1.26B
Spero Therapeutics Inc (SPRO) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported SPRO revenue for 2026-06-30 was $258.0K. Net income was -$16.8M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
SPRO currently screens at market cap $149.5M and trailing P/E 9.6. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the SPRO and TYL stock pages for the full models.
Not investment advice.